Егор Гугучкин

Mr. Егор Гугучкин

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
AGAnastasiia Gurianova
Anastasiia Gurianova
APAnastasiia Pestruilova
Anastasiia Pestruilova
ABAleksandra Beliaeva
Aleksandra Beliaeva
AKArtem Kasianov
Artem Kasianov
ЛМЛюдмила Михайлова
Людмила Михайлова
EKEvgeny Karpulevich
Evgeny Karpulevich
DeepVariant has revolutionized the field of genetic variant identification by reframing variant detection as an image classification problem. However, despite its wide adoption in bioinformatics workflows, the tool continues to evolve mainly through the expansion of training datasets, while its core neural network architecture—Inception V3—has remained unchanged. In this study, we revisited the DeepVariant design and presented a prototype of a modernized version that supports alternative neural network backbones. As a proof of concept, we replaced the legacy Inception V3 model with a mid-sized EfficientNet model and evaluated its performance using the benchmark dataset from the Genome in a Bottle (GIAB) project. Alternative architecture demonstrated faster convergence, a twofold reduction in the number of parameters, and improved accuracy in variant identification. On the test dataset, updated workflow achieved consistent improvements of +0.1% in SNP F1-score, enabling the detection of up to several hundred additional true variants per genome. These results show that optimizing the neural architecture alone can enhance the accuracy, robustness, and efficiency of variant calling, thereby improving the overall quality of sequencing data analysis.

13 July 2024 in BMC Bioinformatics
Verified
Journal Article
Open access
PDF file
ЕГЕгор Гугучкин
Егор Гугучкин
AKArtem Kasianov
Artem Kasianov
MBMaksim Belenikin
Maksim Belenikin
GZGaukhar Zobkova
Gaukhar Zobkova
EKEkaterina Kosova
Ekaterina Kosova
EKEvgeny Karpulevich
Evgeny Karpulevich
Motivation: Alignment of reads to a reference genome sequence is one of the key steps in the analysis of human whole-genome sequencing data obtained through Next-generation sequencing (NGS) technologies. The quality of the subsequent steps of the analysis, such as the results of clinical interpretation of genetic variants or the results of a genome-wide association study, depends on the correct identification of the position of the read as a result of its alignment. The amount of human NGS whole-genome sequencing data is constantly growing. There are a number of human genome sequencing projects worldwide that have resulted in the creation of large-scale databases of genetic variants of sequenced human genomes. Such information about known genetic variants can be used to improve the quality of alignment at the read alignment stage when analysing sequencing data obtained for a new individual, for example, by creating a genomic graph. While existing methods for aligning reads to a linear reference genome have high alignment speed, methods for aligning reads to a genomic graph have greater accuracy in variable regions of the genome. The development of a read alignment method that takes into account known genetic variants in the linear reference sequence index allows combining the advantages of both sets of methods. Results: In this paper, we present the minimap2_index_modifier tool, which enables the construction of a modified index of a reference genome using known single nucleotide variants and insertions/deletions (indels) specific to a given human population. The use of the modified minimap2 index improves variant calling quality without modifying the bioinformatics pipeline and without significant additional computational overhead. Using the PrecisionFDA Truth Challenge V2 benchmark data (for HG002 short-read data aligned to the GRCh38 linear reference (GCA_000001405.15) with parameters k = 27 and w = 14) it was demonstrated that the number of false negative genetic variants decreased by more than 9500, and the number of false positives decreased by more than 7000 when modifying the index with genetic variants from the Human Pangenome Reference Consortium.

2 December 2025 in Cells
Verified
Journal Article
Open access
PDF file
MSMargarita Shedenkova
Margarita Shedenkova
AGAnastasiia Gurianova
Anastasiia Gurianova
Irina KrasilnikovaIrina Krasilnikova
Irina Krasilnikova
ASAnastasia Sudina
Anastasia Sudina
EKEvgeny Karpulevich
Evgeny Karpulevich
DSDiana Salikhova
Diana Salikhova
Neurodegenerative diseases pose a significant challenge to modern medicine. Despite significant advances in neurology, current therapeutic approaches often prove insufficient to treat such disorders. This study investigates the neuroprotective effect of extracellular vesicles derived from glial derivates of human-induced pluripotent stem cells. The extracellular vesicle’s cargo was characterised by proteomic analysis. The neuroprotective effect was assessed using a model of glutamate excitotoxicity performed on a primary culture of cortical neuroglial cells. The viability of cells was estimated using the MTT test and morphometric analyses. A comprehensive methodology was applied to investigate intracellular mechanisms, integrating assessments of intracellular calcium concentrations, mitochondrial membrane potential, and targeted inhibition of the PI3K-Akt pathway. Transcriptomic analysis of neuroglial cultures was used to validate the role of obtained mechanisms of extracellular vesicle’s neuroprotective effect. The obtaining results demonstrated the improvement of neuronal survival by reducing intracellular calcium levels and stabilising mitochondrial membrane potential under glutamate-induced excitotoxicity via PI3K-Akt signalling pathway activation. Moreover, the vesicles contained proteins that contribute to preventing apoptotic processes, activating regeneration of the nervous system, and modulating calcium ion transport and are associated with redox processes. Further transcriptomic analyses of neuroglial cultures treated with EVs showed an up-regulation of genes associated with regeneration, inhibition of calcium ion transport, regulation of membrane depolarisation, and negative regulation of apoptotic pathways.

16 November 2024 in Cancers
Verified
Journal Article
Open access
PDF file
GZGalina Sergeevna Zakharova
Galina Sergeevna Zakharova
MSMaria Suntsova
Maria Suntsova
ERElizaveta Rabushko
Elizaveta Rabushko
Tharaa MohammadTharaa Mohammad
Tharaa Mohammad
ADAlexey Drobyshev
Alexey Drobyshev
ABAnton A. Buzdin
Anton A. Buzdin
Background: In clinical practice, various methods are used to identify ALK gene rearrangements in tumor samples, ranging from “classic” techniques, such as IHC, FISH, and RT-qPCR, to more advanced highly multiplexed approaches, such as NanoString technology and NGS panels. Each of these methods has its own advantages and disadvantages, but they share the drawback of detecting only a restricted (although sometimes quite extensive) set of preselected biomarkers. At the same time, whole transcriptome sequencing (WTS, RNAseq) can, in principle, be used to detect gene fusions while simultaneously analyzing an incomparably wide range of tumor characteristics. However, WTS is not widely used in practice due to purely analytical limitations and the high complexity of bioinformatic analysis, which requires considerable expertise. In particular, methods to detect gene fusions in RNAseq data rely on the identification of chimeric reads. However, the typically low number of true fusion reads in RNAseq limits its sensitivity. In a previous study, we observed asymmetry in the RNAseq exon coverage of the 3′ partners of some fusion transcripts. In this study, we conducted a comprehensive evaluation of the accuracy of ALK fusion detection through an analysis of differences in the coverage of its tyrosine kinase exons. Methods: A total of 906 human cancer biosamples were subjected to analysis using experimental RNAseq data, with the objective of determining the extent of asymmetry in ALK coverage. A total of 50 samples were analyzed, comprising 13 samples with predicted ALK fusions and 37 samples without predicted ALK fusions. These samples were assessed by targeted sequencing with two NGS panels that were specifically designed to detect fusion transcripts (the TruSight RNA Fusion Panel and the OncoFu Elite panel). Results: ALK fusions were confirmed in 11 out of the 13 predicted cases, with an overall accuracy of 96% (sensitivity 100%, specificity 94.9%). Two discordant cases exhibited low ALK coverage depth, which could be addressed algorithmically to enhance the accuracy of the results. It was also important to consider read strand specificity due to the presence of antisense transcripts involving parts of ALK. In a limited patient sample undergoing ALK-targeted therapy, the algorithm successfully predicted treatment efficacy. Conclusions: RNAseq exon coverage analysis can effectively detect ALK rearrangements.

4 November 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
MSMargarita Shedenkova
Margarita Shedenkova
AGAnastasiia Gurianova
Anastasiia Gurianova
Irina KrasilnikovaIrina Krasilnikova
Irina Krasilnikova
ASAnastasia Sudina
Anastasia Sudina
EKEvgeny Karpulevich
Evgeny Karpulevich
DSDiana Salikhova
Diana Salikhova
Neurodegenerative diseases pose a significant challenge to modern medicine. Despite significant advances in neurology, current therapeutic approaches often prove insufficient to treat such disorders. This study investigates the neuroprotective effect of extracellular vesicles derived from glial derivates of human induced pluripotent stem cells. The extra-cellular vesicle’s cargo was characterised by proteomic analysis. They neuroprotective ef-fect was assessed using a model of glutamate excitotoxicity performed on primary culture of cortical neurons. The viability of cortical neurons was estimated using the MTT test and morphometric analyses. A comprehensive methodology was applied to investigate intra-cellular mechanisms, integrating assessments of intracellular calcium concentrations, mitochondrial membrane potential, and targeted inhibition of the PI3K‑Akt pathway. Transcriptomic analysis of cortical neurons was used to validated the role of obtained mechanisms of extracellular vesicle’s neuroprotective effect. The obtaining results demon-strated the improvement of neuronal survival by reducing intracellular calcium levels, and stabilizing mitochondrial membrane potential under glutamate-induced excitotoxi-city via PI3K-Akt signaling pathway activation. Moreover, the vesicles contained proteins that contribute to preventing apoptotic processes, activating regeneration of nervous sys-tem, modulating of calcium ion transport and associated with redox processes. Further transcriptomic analyses of neuroglial cultures treated with EVs showed up-regulation of genes associated with regeneration, inhibition of calcium ion transport, regulation of membrane depolirisation and negative regulation of apoptotic pathways.

19 August 2024 in BMC Bioinformatics
Verified
Journal Article
Open access
PDF file
ЕГЕгор Гугучкин
Егор Гугучкин
AKArtem Kasianov
Artem Kasianov
MBMaksim Belenikin
Maksim Belenikin
GZGaukhar Zobkova
Gaukhar Zobkova
EKEkaterina Kosova
Ekaterina Kosova
EKEvgeny Karpulevich
Evgeny Karpulevich